Silver Book Fact

Fact image

The Impact of Personalized Medicine on Cancer Survival in Years

Munoz J, Kurzrock R. Targeted Therapy in Rare Cancers: Adopting the orphans. Nat Rev Clin Oncol. 2012; 9(11): 631-42. http://www.ncbi.nlm.nih.gov/pubmed/22965154

Reference

Title
Targeted Therapy in Rare Cancers: Adopting the orphans
Publication
Nat Rev Clin Oncol
Publication Date
2012
Authors
Munoz J, Kurzrock R
Volume & Issue
Volume 9, Issue 11
Pages
631-42
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Death rates from breast cancer declined by an average of 2.3% per year between 1990 and 2002 because of earlier detection through screening, better awareness, and improved treatments.  
  • There are nearly 14.5 million people in the U.S. living with a history of cancer.  
  • “Among women age 65 and over, the percentage who had a mammogram within the preceding 2 years almost tripled from 23% in 1987 to 64% in 2005.”  
  • The standard treatment for prostate cancer used to require radical prostatectomy. Now, less invasive therapies like brachytherapy have been shown to have equal outcomes with fewer side effects.  
  • The 5-year survival rate for all cancers diagnosed from 1996-2003 is 66%, up from 50% in 1975-1977. This improvement reflects progress in early diagnosis and improvements in treatment.